Tricyclic antidepressants in the treatment of poststroke depression.
Depression is a serious complication of stroke. Although tricyclic antidepressants have well-established efficacy in the treatment of functional depression, they are not often used to treat depression following stroke. Studies have identified two types of depression in patients following stroke: major depression and minor depression. Longitudinal studies indicate that untreated major depression may last about 1 year, whereas untreated minor depression may last more than 2 years. Patients with depression who are not treated with antidepressant medication have been found to do more poorly on several measures of physical and cognitive rehabilitation than depressed patients who are treated. Two double-blind drug treatment studies of depression following stroke have been done. Although adverse side effects were reported in both studies, serious side effects were no more common in the active drug group than in the placebo group. Both studies, however, reported significantly better outcome, measured by depression scores or activities of daily living, in patients treated with nortriptyline or trazodone than in placebo-treated controls. Thus, although the use of antidepressant medication requires caution, the recognition and treatment of depression in patients who have had a stroke may result in a significant enhancement of both physical and cognitive recovery as well as emotional state.
Fedoroff
J P
JP
Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Robinson
R G
RG
D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000150:complications*; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy* / Q000209:etiology; D004311:Double-Blind Method; D006801:Humans; D010043:Outcome and Process Assessment, Health Care; D011897:Random Allocation
D000929:Antidepressive Agents, Tricyclic